- Home
- NVAX vs WT Comparison
NVAX vs WT Comparison
Compare NVAX & WT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- WT
- Stock Information
- Founded
- NVAX 1987
- WT 1985
- Country
- NVAX United States
- WT United States
- Employees
- NVAX N/A
- WT N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- WT Investment Bankers/Brokers/Service
- Sector
- NVAX Health Care
- WT Finance
- Exchange
- NVAX Nasdaq
- WT Nasdaq
- Market Cap
- NVAX 1.3B
- WT 1.4B
- IPO Year
- NVAX 1995
- WT N/A
- Fundamental
- Price
- NVAX $7.34
- WT $9.44
- Analyst Decision
- NVAX Buy
- WT Buy
- Analyst Count
- NVAX 5
- WT 7
- Target Price
- NVAX $19.00
- WT $12.21
- AVG Volume (30 Days)
- NVAX 14.2M
- WT 1.2M
- Earning Date
- NVAX 05-08-2025
- WT 07-25-2025
- Dividend Yield
- NVAX N/A
- WT 1.27%
- EPS Growth
- NVAX N/A
- WT N/A
- EPS
- NVAX 2.97
- WT 0.37
- Revenue
- NVAX $1,254,962,000.00
- WT $438,981,000.00
- Revenue This Year
- NVAX $40.01
- WT $6.61
- Revenue Next Year
- NVAX N/A
- WT $5.61
- P/E Ratio
- NVAX $2.47
- WT $25.69
- Revenue Growth
- NVAX 25.92
- WT 20.66
- 52 Week Low
- NVAX $5.01
- WT $7.47
- 52 Week High
- NVAX $23.86
- WT $12.45
- Technical
- Relative Strength Index (RSI)
- NVAX 55.86
- WT 54.17
- Support Level
- NVAX $6.84
- WT $9.24
- Resistance Level
- NVAX $7.62
- WT $9.74
- Average True Range (ATR)
- NVAX 0.55
- WT 0.21
- MACD
- NVAX 0.07
- WT -0.04
- Stochastic Oscillator
- NVAX 50.52
- WT 29.10
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About WT WisdomTree Inc.
WisdomTree Inc is a financial innovator, offering a well-diversified suite of exchange-traded products (ETPs), models and solutions. It offers a broad range of ETFs and exchange-traded products (ETPs). The firm also engages in developing next-generation digital products and structures, including digital funds and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime. The Company conducts business under a single operating segment as an ETP sponsor and asset manager.